Additional Information

Description

The Kenalog 10 mg/mL Vial, with a volume of 5 mL, is a pharmaceutical solution containing triamcinolone acetonide, a corticosteroid. This medication is administered by healthcare professionals to address various inflammatory conditions. The sterile and non-returnable nature of the vial ensures product integrity and patient safety.

With a concentration of 10 mg/mL, this Kenalog vial provides a precise and measured dose for medical interventions. The 5 mL volume offers flexibility in dosage, allowing healthcare providers to tailor the treatment to individual patient needs.

Triamcinolone acetonide, the active ingredient in Kenalog, exhibits anti-inflammatory properties, making it effective in managing conditions such as allergies, skin disorders, and joint inflammation. Healthcare professionals value its reliability in providing targeted relief.

Additional Information

Description

Kenalog injection is a 10 mg triamcinolone acetonide per ml injection. It is packed in a 5 ml multiple-dose vial or 50 mg triamcinolone acetonide per 5 ml. Each ml of sterile aqueous suspension (other than 10 mg triamcinolone acetonide) provides 0.65% sodium chloride, 0.99% benzyl alcohol, 0.75% carboxymethyl cellulose sodium, and 0.04% polysorbate 80. It is a synthetic glucocorticoid that acts as an anti-inflammatory. KENALOG-10 injection is used via intradermal or intra-articular routes only. The injection is preferred when oral therapy is not suitable. Note that it should not be used intramuscular or intravenous. Kenalog injection is used as an adjunctive therapy in acute gouty arthritis, rheumatoid arthritis, psoriatic arthritis, multiple sclerosis, and acute rheumatic carditis.

It is indicated for various allergic reactions that include asthma, contact or atopic dermatitis, drug-related hypersensitivity reactions, seasonal rhinitis, transfusion reaction and serum sickness. Kenalog injection is also used in dermatologic diseases such as exfoliative erythroderma, Stevens-Johnson syndrome, pemphigus, mycosis fungoides etc. Other indications for Kenalog injection include gastrointestinal diseases such as ulcerative colitis, Neoplastic disease including lymphomas and leukemia, and ophthalmic diseases.